|
|
| (11) | Number of the document | C 2701720 |
| (68) | Number of the document | 2701720 |
| (21) | Application number for Supplementary Protection Certificate | PA 2022 529 |
| (22) | Date of filing the application | 2022-12-16 |
| (41) | Date of publication of the application | 2023-01-10 |
| Date of publication of SPC | 2024-09-25 | |
| (24) | Date of coming into effect of SPC | 2032-04-26 |
| (71) |
Oncopeptides AB,
Västra Trädgårdsgatan 15, 111 53 Stockholm,
SE
|
| (73) |
Oncopeptides Innovation AB ,
Luntmakargatan 46, 111 37 Stockholm,
SE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/22/1669, 2022-08-17 |
| (94) | 2037-04-25 |
| (95) | Melfalano flufenamido hidrochloridas |
| SPC granted |